Abstract
Poly (β-malic acid) (PMLA) could be used as a polymeric drug carrier due to its biological properties. In this paper, different definite molecular weights of PMLA for use as a polymer drug carrier were synthesized by adjusting monomer/initiator ratio in polymerization reaction. The yield of benzyl-β-malolactonate (MLABz, the major intermediate product in synthesis of PMLA) increased from the earlier reported 12 % to 32 %; and the anti-tumor drug 10-hydroxycamptothecin (HCPT) was attached to the PMLA (Mw 13 kDa) backbone through a glycine linker. The conjugation efficiency and drug release characteristics of the conjugate were determined. HCPT release from PMLA–HCPT conjugates occurred at a faster rate at an acidic pH compared with neutral pH (7.4). After 16 h of incubation at pH 5.6, 6.8 and 7.4, the released HCPT was 76.8 %, 47.2 % and 18.1 %, respectively. Human colorectal cancer SW480 cells were used to investigate the cytotoxicity of PMLA–HCPT conjugates under different pHs in vitro. The cytotoxicity of conjugate was lower than that of free HCPT in physiological pH, while it was higher in the pH 6.8 buffer solution compared to pH 7.4, due to the release of free HCPT from the PMLA–HCPT conjugates by hydrolysis. It is implied that PMLA–HCPT conjugates could be used as a promising anti-tumor polymeric prodrug.
Similar content being viewed by others
References
Pasut G, Veronese FM (2009) Adv Drug Deliv Rev 61:1177
Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R, Searle F (2001) J Control Release 74:135
Lopez-Davila V, Seifalian AM, Loizidou M (2012) Curr Opin Pharmacol 12:414
Felber AE, Dufresne MH, Leroux JC (2012) Adv Drug Deliv Rev 64:979
Khandare J, Minko T (2006) Prog Polym Sci 31:359
Fan L, Wu H, Zhang H, Li F, Yang T (2009) Polym Compos 31:51
Fan L, Li F, Zhang H, Wang Y, Cheng C, Li X, Gu CH, Yang Q, Wu H, Zhang S (2010) Biomaterials 31:5634
Canal F, Sanchis J, Vicent MJ (2011) Curr Opin Biotechnol 22:894
Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, Tan W (2012) Nanomedicine 7:1253
Ringsdorf H (1975) J Polym Sci Polym Symp 51:135
Ljubimova JY, Fujita M, Ljubimov AV, Torchilin VP, Black KL, Holler E (2008) Nanomedicine 3:247
Braud C, Bunel C, Vert M (1985) Polym Bull 13:293
Inoue S, Ding H, Portilla-Arias J, Hu J, Konda B, Fujita M, Espinoza A, Suhane S, Riley M, Gates M, Patil R, Penichet ML, Ljubimov AV, Black KL, Holler E, Ljubimova JY (2011) Cancer Res 71:1454
Ouchi T, Kobayashi H, Banba T (1990) Br Polym J 23:221
Ohya Y, Hirai K, Ouchi T (1992) Makromol Chem 193:1881
Huang ZW, Laurent V, Chetouani G, Ljubimova JY, Holler E, Benvegnu T, Loyer P, Cammas-Marion S (2012) Int J Pharm 423:84
Pendri A, Gilbert CW, Soundararajan S, Bolikal D, Shorr RGL, Greenwald RB (1996) J Bioact Compat Polym 11:122
Greenwald RB, Pendri A, Bolikal D, Gilbert CW (1994) Bioorg Med Chem Lett 4:2465
Greenwald RB, Gilbert CW, Pendri A, Conover CD, Xia J, Martinez A (1996) J Med Chem 39(424)
Yamaoka T, Tabata Y, Ikada Y (1994) J Pharm Sci 83:601
Manitchotpisit P, Skory CD, Peterson SW, Price NP, Vermillion KE, Leathers TD (2012) J Ind Microbiol Biotechnol 39:125
Leathers TD, Manitchotpisit P (2013) Biotechnol Lett 35:83
Qiao CS, Zhong K, Hao HX, Jia YY (2012) J Appl Biomater Biom 108:121
Kajiyama T, Kobayashi H, Taguchi T, Kataoka K, Tanaka J (2004) Biomacromolecules 5:169
Coulembier O, Degée P, Hedrick JL, Dubois P (2006) Prog Polym Sci 31:723
Ljubimova JY, Fujita M, Khazenzon NM, Lee BS, Wachsmann-Hogiu S, Farkas DL, Black KL, Holler E (2008) Chem Biol Interact 171:195
Fujita M, Lee B, Khazenzon NM, Penichel ML, Wawrowsky KA, Patil R, Ding H, Black KL, Ljubimova JY (2007) J Control Release 122:356
Li QY, Zu YG, Shi RZ, Yao LP (2006) Curr Med Chem 13:2021
Mi Z, Burke TG (1994) Biochemistry-Us 33:10325
Hatefi A, Amsden B (2002) Pharm Res 19:1389
Li Q, Liu C, Zhao X, Zu Y, Wang Y, Zhang B, Zhao D, Zhao Q, Su L, Gao Y, Sun B (2011) Int J Nanomedicine 6:397
Minko T, Paranjpe PV, Qiu B, Lalloo A, Won R, Stein S, Sinko PJ (2002) Cancer Chemother Pharmacol 50:143
Cho J, Chun C, Kuh H, Song S (2012) Eur J Pharm Biopharm 81:582
Dharap SS, Qiu B, Williams GC, Sinko P, Steind S, Minko T (2003) J Control Release 91:61
Greenwald RB (2001) J Control Release 74:159
Cammas S, Renard I, Langlois VR, Guerin P (1996) Polymer 37:4215
Cao N, Feng S (2008) Biomaterials 29:3856
Abdellaoui K, Bousttaa M, Vert M, Morjanib H, Manfaitb M (1998) Eur J Pharm Sci 6:61
Ding H, Inoue S, Ljubimov AV, Patil R, Portilla-Arias J, Hu J, Konda B, Wawrowsky KA, Manabu Fujitab NK, Takako Sasakie KLB, Holler E, Ljubimova JY (2010) PNAS 107:18143
Portilla-Arias J, Patil R, Hu J, Ding H, Black KL, Garcia-Alvarez M, Munoz-Guerra S, Ljubimova JY, Holler E (2010) J Nanotechnol. doi:10.1155/2010/825363
Wojtkowiak JW, Verduzco D, Schramm KJ, Gillies RJ (2011) Mol Pharm 8:2032
Tian L, Bae YH (2012) Colloid Surface B 99:116
Acknowledgments
This study was supported by National Nature Science Foundation of China grants No. 81271687 and No. 30970788.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Youbei Qiao and Xiao Duan contributed equally to this work.
Rights and permissions
About this article
Cite this article
Qiao, Y., Duan, X., Fan, L. et al. Synthesis of controlled molecular weight poly (β-malic acid) and conjugation with HCPT as a polymeric drug carrier. J Polym Res 21, 397 (2014). https://doi.org/10.1007/s10965-014-0397-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10965-014-0397-4